These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 28504196)

  • 1. Human subthalamic nucleus - Automatic auditory change detection as a basis for action selection.
    Heldmann M; Münte TF; Paracka L; Beyer F; Brüggemann N; Saryyeva A; Rasche D; Krauss JK; Tronnier VM
    Neuroscience; 2017 Jul; 355():141-148. PubMed ID: 28504196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subthalamic deep brain stimulation improves auditory sensory gating deficit in Parkinson's disease.
    Gulberti A; Hamel W; Buhmann C; Boelmans K; Zittel S; Gerloff C; Westphal M; Engel AK; Schneider TR; Moll CK
    Clin Neurophysiol; 2015 Mar; 126(3):565-74. PubMed ID: 25085452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive timing functions of cortical beta oscillations are impaired in Parkinson's disease and influenced by L-DOPA and deep brain stimulation of the subthalamic nucleus.
    Gulberti A; Moll CK; Hamel W; Buhmann C; Koeppen JA; Boelmans K; Zittel S; Gerloff C; Westphal M; Schneider TR; Engel AK
    Neuroimage Clin; 2015; 9():436-49. PubMed ID: 26594626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional and effective connectivity in subthalamic local field potential recordings of patients with Parkinson's disease.
    Hohlefeld FU; Huchzermeyer C; Huebl J; Schneider GH; Nolte G; Brücke C; Schönecker T; Kühn AA; Curio G; Nikulin VV
    Neuroscience; 2013 Oct; 250():320-32. PubMed ID: 23876322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mismatch negativity-like potential (MMN-like) in the subthalamic nuclei in Parkinson's disease patients.
    Minks E; Jurák P; Chládek J; Chrastina J; Halámek J; Shaw DJ; Bareš M
    J Neural Transm (Vienna); 2014 Dec; 121(12):1507-22. PubMed ID: 24809684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effect of dopa and subthalamic stimulation on vestibular activity in Parkinson's disease.
    Pötter-Nerger M; Reich MM; Colebatch JG; Deuschl G; Volkmann J
    Mov Disord; 2012 Sep; 27(10):1268-75. PubMed ID: 22693156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subthalamic local field potential oscillations during ongoing deep brain stimulation in Parkinson's disease.
    Rossi L; Marceglia S; Foffani G; Cogiamanian F; Tamma F; Rampini P; Barbieri S; Bracchi F; Priori A
    Brain Res Bull; 2008 Jul; 76(5):512-21. PubMed ID: 18534260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subthalamic stimulation and levodopa modulate cortical reactivity in Parkinson's patients.
    Casula EP; Stampanoni Bassi M; Pellicciari MC; Ponzo V; Veniero D; Peppe A; Brusa L; Stanzione P; Caltagirone C; Stefani A; Koch G
    Parkinsonism Relat Disord; 2017 Jan; 34():31-37. PubMed ID: 27771287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced target identification in STN-DBS with beta power of combined local field potentials and spiking activity.
    Verhagen R; Zwartjes DG; Heida T; Wiegers EC; Contarino MF; de Bie RM; van den Munckhof P; Schuurman PR; Veltink PH; Bour LJ
    J Neurosci Methods; 2015 Sep; 253():116-25. PubMed ID: 26079495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic therapy promotes lateralized motor activity in the subthalamic area in Parkinson's disease.
    Androulidakis AG; Kühn AA; Chen CC; Blomstedt P; Kempf F; Kupsch A; Schneider GH; Doyle L; Dowsey-Limousin P; Hariz MI; Brown P
    Brain; 2007 Feb; 130(Pt 2):457-68. PubMed ID: 17213215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of lead trajectory and electrode position to neuropsychological outcomes of subthalamic neurostimulation in Parkinson's disease: results from a randomized trial.
    Witt K; Granert O; Daniels C; Volkmann J; Falk D; van Eimeren T; Deuschl G
    Brain; 2013 Jul; 136(Pt 7):2109-19. PubMed ID: 23801735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectral analysis of field potential recordings by deep brain stimulation electrode for localization of subthalamic nucleus in patients with Parkinson's disease.
    Miyagi Y; Okamoto T; Morioka T; Tobimatsu S; Nakanishi Y; Aihara K; Hashiguchi K; Murakami N; Yoshida F; Samura K; Nagata S; Sasaki T
    Stereotact Funct Neurosurg; 2009; 87(4):211-8. PubMed ID: 19571612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of levodopa and subthalamic nucleus deep brain stimulation on bradykinesia in Parkinson's disease.
    Timmermann L; Braun M; Groiss S; Wojtecki L; Ostrowski S; Krause H; Pollok B; Südmeyer M; Ploner M; Gross J; Maarouf M; Voges J; Sturm V; Schnitzler A
    Mov Disord; 2008 Jan; 23(2):218-27. PubMed ID: 18044706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oscillatory subthalamic nucleus activity is modulated by dopamine during emotional processing in Parkinson's disease.
    Huebl J; Spitzer B; Brücke C; Schönecker T; Kupsch A; Alesch F; Schneider GH; Kühn AA
    Cortex; 2014 Nov; 60():69-81. PubMed ID: 24713195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transitional Probabilities Are Prioritized over Stimulus/Pattern Probabilities in Auditory Deviance Detection: Memory Basis for Predictive Sound Processing.
    Mittag M; Takegata R; Winkler I
    J Neurosci; 2016 Sep; 36(37):9572-9. PubMed ID: 27629709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pedunculopontine nucleus evoked potentials from subthalamic nucleus stimulation in Parkinson's disease.
    Neagu B; Tsang E; Mazzella F; Hamani C; Moro E; Hodaie M; Lozano AM; Chen R
    Exp Neurol; 2013 Dec; 250():221-7. PubMed ID: 24095981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease.
    Funkiewiez A; Ardouin C; Krack P; Fraix V; Van Blercom N; Xie J; Moro E; Benabid AL; Pollak P
    Mov Disord; 2003 May; 18(5):524-30. PubMed ID: 12722166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of subthalamic nucleus deep brain stimulation and Duodopa in the treatment of advanced Parkinson's disease.
    Merola A; Zibetti M; Angrisano S; Rizzi L; Lanotte M; Lopiano L
    Mov Disord; 2011 Mar; 26(4):664-70. PubMed ID: 21469197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of levodopa and ongoing deep brain stimulation on subthalamic beta oscillations in Parkinson's disease.
    Giannicola G; Marceglia S; Rossi L; Mrakic-Sposta S; Rampini P; Tamma F; Cogiamanian F; Barbieri S; Priori A
    Exp Neurol; 2010 Nov; 226(1):120-7. PubMed ID: 20713047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiological registration of phonological perception in the subthalamic nucleus of patients with Parkinson's Disease.
    De Letter M; Aerts A; Van Borsel J; Vanhoutte S; De Taeye L; Raedt R; van Mierlo P; Boon P; Van Roost D; Santens P
    Brain Lang; 2014 Nov; 138():19-26. PubMed ID: 25265552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.